This report provides a deep and detailed analysis of: implants, dermal fillers, neuromodulators, and lasers, light-based systems, and other energy-based devices.
Find out which segments will account for the greatest share, as well as which regions will exceed a 14% CAGR, through 2017.
1. EXECUTIVE SUMMARY 1.1 Aesthetic Implants 1.2 Dermal Fillers & Neuromodulators 1.3 Lasers, Light-Based Systems, and Other Energy-Based Devices Exhibit 1-1: The Global Market for Aesthetic Devices by Product Type from 2010-2017 Exhibit 1-2: The Global Market for Aesthetic Devices by Region from 2010-2017 Exhibit 1-3: The Global Market Forecast for Aesthetic Implants by Type from 2010-2017 Exhibit 1-4: The Global Market Forecast for Aesthetic Implants by Region from 2010-2017 Exhibit 1-5: The Global Market Forecast for Dermal Fillers and Neuromodulators from 2010-2017 Exhibit 1-6: The Global Market Forecast for Dermal Fillers and Neuromodulators by Region from 2010-2017 Exhibit 1-7: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017 Exhibit 1-8: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Region from 2010-2017 2. AESTHETIC IMPLANTS 2.1 Types of Products 2.1.1 Breast Implants 2.1.2 Facial Implants 2.1.3 Other Bodily Implants 2.1.4 Tissue Expanders for Breast Reconstructions 2.2 Procedure Forecasts and Market Analyses 2.2.1 U.S. Procedure Forecasts and Market Analyses 2.2.1.1 Breast Augmentation 2.2.1.2 Facial Implants 2.2.1.3 Other Bodily Implants 2.2.1.4 Breast Reconstruction 2.2.1.5 U.S. Supplier Shares 2.2.2 European Procedure Forecasts and Market Analyses 2.2.2.1 Breast Augmentation 2.2.2.2 Facial Implants 2.2.2.3 Other Bodily Implants 2.2.2.4 Breast Reconstruction 2.2.3 Procedure Forecasts and Market Analyses for Countries in Asia-Pacific and the Rest-of-the-World 2.2.3.1 Breast Augmentation 2.2.3.2 Facial Implants 2.2.3.3 Other Bodily Implants 2.2.3.4 Breast Reconstruction 2.2.4 OUS Supplier Shares Exhibit 2-1: Types of Aesthetic Implants Exhibit 2-2: Selected Aesthetic Implants in 2012 Exhibit 2-3: The Global Market Forecast for Aesthetic Implants from 2010-2017 Exhibit 2-4: The U.S. Market Forecast for Aesthetic Implants from 2010-2017 Exhibit 2-5: The U.S. Market Forecast for Aesthetic Implants by Type from 2010-2017 Exhibit 2-6: The U.S. Market Forecast for Breast Augmentation from 2010-2017 2-14 Exhibit 2-7: The U.S. Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017 Exhibit 2-8: The U.S. Market Forecast for Facial Implants from 2010-2017 Exhibit 2-9: The U.S. Market Forecast for Other Bodily Implants from 2010-2017 Exhibit 2-10: The U.S. Market Forecast for Breast Reconstructions from 2010-2017 Exhibit 2-11: U.S. Supplier Shares in 2010 and 2011 Exhibit 2-12: The European Market Forecast for Aesthetic Implants from 2010-2017 Exhibit 2-13: The European Market Forecast for Aesthetic Implants by Type from 2010-2017 Exhibit 2-14: The European Market Forecast for Breast Augmentation from 2010-2017 Exhibit 2-15: The European Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017 Exhibit 2-16: The European Market Forecast for Facial Implants from 2010-2017 Exhibit 2-17: The European Market Forecast for Other Bodily Implants from 2010-2017 Exhibit 2-18: The European Market Forecast for Breast Reconstructions from 2010-2017 Exhibit 2-19: The AP & ROW Market Forecast for Aesthetic Implants from 2010-2017 Exhibit 2-20: The AP & ROW Market Forecast for Aesthetic Implants by Type from 2010-2017 Exhibit 2-21: The AP & ROW Market Forecast for Breast Augmentation from 2010-2017 Exhibit 2-22: The AP & ROW Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017 Exhibit 2-24: The AP & ROW Market Forecast for Other Bodily Implants from 2010-2017 Exhibit 2-25: The AP & ROW Market Forecast for Breast Reconstructions from 2010-2017 Exhibit 2-26: OUS Supplier Shares in 2010 and 2011 3. DERMAL FILLERS & NEUROMODULATORS 3.1 Product Types 3.2 Procedure Forecasts and Market Analyses 3.2.1 U.S. Procedure Forecasts and Market Analyses 3.2.1.1 Dermal Fillers 3.2.1.2 Neuromodulators 3.2.1.3 U.S. Supplier Shares 3.2.2 European Procedure Forecasts and Market Analyses 3.2.2.1 Dermal Fillers 3.2.2.2 Neuromodulators 3.2.3 Procedure Forecasts and Market Analyses for Countries in Asia-Pacific and the Rest-of-the-World 3.2.3.1 Dermal Fillers 3.2.3.2 Neuromodulators 3.2.4 OUS Supplier Shares Exhibit 3-1: Dermal Fillers & Neuromodulators Exhibit 3-2: Advantages & Disadvantages of Dermal Fillers & Neuromodulators Exhibit 3-3: Selected Dermal Fillers & Neuromodulators in 2012 Exhibit 3-4: The Global Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017 Exhibit 3-5: The U.S. Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017 Exhibit 3-6: The U.S. Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017 Exhibit 3-7: The U.S. Market Forecast for Dermal Fillers from 2010-2017 Exhibit 3-8: The U.S. Market Forecast for Neuromodulators from 2010-2017 Exhibit 3-9: U.S. Supplier Shares in 2010 and 2011 Exhibit 3-10: The European Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017 Exhibit 3-11: The European Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017 Exhibit 3-12: The European Market Forecast for Dermal Fillers from 2010-2017 Exhibit 3-13: The European Market Forecast for Neuromodulators from 2010-2017 Exhibit 3-14: The AP & ROW Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017 Exhibit 3-15: The AP & ROW Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017 Exhibit 3-16: The AP & ROW Market Forecast for Dermal Fillers from 2010-2017 Exhibit 3-17: The AP & ROW Market Forecast for Neuromodulators from 2010-2017 Exhibit 3-18: OUS Supplier Shares in 2010 and 2011 4. LASERS, LIGHT-BASED SYSTEMS, & OTHER ENERGY-BASED DEVICES 4.1 Product Types 4.2 Advantages and Disadvantages of Lasers, Light-Based Systems, and Other Energy-Based Devices for Aesthetic Applications 4.3 Procedure Forecasts and Market Analyses 4.3.1 U.S. Procedure Forecasts and Market Analyses 4.3.1.1 Lasers, Light-Based, and Other Energy-Based Systems 4.3.1.2 Endovenous Vein Ablations 4.3.1.3 U.S. Supplier Shares 4.3.2 OUS Procedure Forecasts and Market Analyses . 4.3.2.1 European Procedure Forecasts and Market Analyses 4.3.2.1.1 Lasers, Light-, and Other Energy-Based Systems 4.3.2.1.2 Endovenous Vein Ablations 4.3.2.2 AP & ROW Procedure Forecasts and Market Analyses 4.3.2.2.1 Lasers, Light-, and Other Energy-Based Systems 4.3.2.2.2 Endovenous Vein Ablations 4.3.2.3 OUS Supplier Shares Exhibit 4-1: Selected Lasers, Light-Based Systems, and Other Energy-Based Devices in 2012 Exhibit 4-2: Advantages & Disadvantages of Lasers, Light-Based Systems, and Other Energy-Based Devices for Aesthetic Procedures Exhibit 4-3: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017 Exhibit 4-4: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Geography from 2010-2017 Exhibit 4-5: The U.S. Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017 Exhibit 4-6: The U.S. Forecast for Aesthetic Procedures Using Lasers, Light-Based Systems, & Other Energy-Based Devices from 2010-2017 Exhibit 4-7: The U.S. Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; & Cryolipolysis Exhibit 4-8: Endovenous Vein Ablations in the U.S. from 2010-2017 Exhibit 4-9: The U.S. Market Forecast for Endovenous Vein Ablations from 2010-2017 Exhibit 4-10: U.S. Supplier Shares in 2010 and 2011 Exhibit 4-11: The European Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017 Exhibit 4-12: The European Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; & Cryolipolysis Exhibit 4-13: Endovenous Vein Ablations in Europe from 2010-2017 Exhibit 4-14: The European Market Forecast for Endovenous Vein Ablations from 2010-2017 Exhibit 4-15: The AP & ROW Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017 Exhibit 4-16: The AP & ROW Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; & Cryolipolysis Exhibit 4-17: Endovenous Vein Ablations in AP & ROW Countries from 2010-2017 Exhibit 4-18: The AP & ROW Market Forecast for Endovenous Vein Ablations from 2010-2017 Exhibit 4-19: OUS Supplier Shares in 2010 and 2011 5. COMPANY PROFILES 5.1 Allergan 5.2 Alma Lasers 5.3 AngioDynamics 5.4 biolitec 5.5 Covidien 5.6 Cutera 5.7 Cynosure 5.8 El. En 5.9 Galderma 5.10 GC Aesthetics 5.11 Lumenis 5.12 Medicis Pharmaceutical 5.13 Mentor Worldwide (Johnson & Johnson) 5.14 Merz Aesthetics 5.15 Palomar Medical Technologies 5.16 PhotoMedex 5.17 sanofi-aventis 5.18 Silimed 5.19 Solta Medical 5.20 Syneron Medical 5.21 ZELTIQ Aesthetics